文献速递围术期管理与 ERAS急腹症与外科感染

血管手术患者围术期压疮不增加死亡率但增加资源利用

Decubitus ulcers in patients undergoing vascular operations do not influence mortality but affect resource utilization.
PubMed 文献 · Surgery · 2017-03-18

基于美国全国住院患者调查的538,808例血管手术成人患者分析显示,围术期压疮患者非择期手术更多、并发症更常见,未调整死亡率翻倍(3% vs 6%),但风险调整后压疮及分期均不增加死亡 odds;压疮使转往中间护理机构 odds 增加2.9倍,总费用为无压疮组的1.6倍。

要点

  • 围术期压疮不独立增加血管手术风险调整后死亡风险。
  • 压疮患者并发症更多,失败救援率翻倍(1.5% vs 3.2%)。
  • 压疮显著增加转中间护理机构 odds(2.9)及总费用(1.6倍)。

核心结论

  • 围术期压疮不 adverse 影响血管手术患者风险调整后死亡率。
  • 压疮患者并发症风险更高且产生可观额外费用。

研究设计与样本

  • 基于 National Impatient Survey 的回顾性队列分析。
  • 纳入538,808例接受血管手术的成人患者。
  • 按有无压疮分层,采用病例组合调整的层次混合模型分析院内死亡、并发症及出院去向。

主要发现

  • 压疮在白人男性 Medicare 受益人中最多见(P < .001)。
  • 压疮患者接受更多非择期血管手术(P < .001)。
  • 伤口、感染及操作相关并发症在压疮患者中更常见(P < .001)。
  • 失败救援率压疮组3.2% vs 无压疮组1.5%(P < .001)。
  • 未调整死亡率压疮组6% vs 无压疮组3%(P < .001)。

关键数值与推荐

  • 风险调整后压疮存在及特定分期均不增加死亡 odds。
  • 压疮增加转中间护理机构调整 odds(OR 2.9,P < .001)。
  • 压疮患者总费用为无压疮组1.6倍($81,149 ± $5,855 vs $49,460 ± $281,P < .001)。

临床怎么用

  • 血管手术患者围术期压疮不应被视为死亡风险独立预测因素。
  • 需关注压疮患者的并发症预防及出院规划,因其转中间护理机构风险高、费用显著增加。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: While it is anticipated that decubitus ulcers are detrimental to outcomes after vascular operations, the contemporary influence of perioperative decubitus ulcers in vascular surgery remains unknown. METHODS: Using the National Impatient Survey, all adult patients who underwent vascular operation were selected. Patients were stratified by the presence or absence (non-decubitus ulcers) of decubitus ulcer. Case-mix adjusted hierarchical mixed-models examined in-hospital mortality, the occurrence of any complication, and discharge disposition. RESULTS: A total of 538,808 cases were analyzed. Decubitus ulcers were most prevalent among Caucasian male Medicare beneficiaries (P < .001). Decubitus ulcer patients also underwent more nonelective vascular operations (P < .001). Wound, infectious, and procedural complications were more common in patients with decubitus ulcers (P < .001). Failure to rescue, defined as mortality after any complication, was more than doubled in decubitus ulcers (non-decubitus ulcers: 1.5%, decubitus ulcers: 3.2%, P < .001). Similarly, unadjusted mortality was also doubled in patients undergoing vascular operation with decubitus ulcers (non-decubitus ulcers: 3%, decubitus ulcers: 6%, P < .001). After risk adjustment among all patients, neither the presence of a decubitus ulcer nor specific ulcer staging increased the adjusted odds of death. Having a decubitus ulcer increased the adjusted odds of discharge to an intermediate care facility (odds ratio 2.9, P < .001). These patients also had 1.6 times the total charges compared to their non-decubitus ulcer cohort (non-decubitus ulcers: $49,460 ± $281 vs decubitus ulcers: $81,149 ± $5,855, P < .001). CONCLUSION: Contrary to common perception, perioperative decubitus ulcer does not adversely affect mortality after vascular operation in patients proceeding to operative intervention. Patients with decubitus ulcers are, however, at higher risk for complications and incur sizeable additional charges.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Mehaffey JH, Politano AD, Bhamidipati CM, et al. Decubitus ulcers in patients undergoing vascular operations do not influence mortality but affect resource utilization. Surgery. 2017. PMID: 28318554. doi:10.1016/j.surg.2017.02.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。